SherriMDonatMDFACS

Surgical Oncology

Professor, Urology, Weill Cornell Medical College Attending Surgeon, Memorial Sloan Kettering Cancer Center

Overview of Dr. Donat

Dr. Sherri Donat is an urologist in New York, NY and is affiliated with Memorial Sloan Kettering Cancer Center. She received her medical degree from University of Oklahoma College of Medicine and has been in practice 30 years. Dr. Donat accepts several types of health insurance, listed below. She is one of 73 doctors at Memorial Sloan Kettering Cancer Center who specialize in Urology. She has more than 100 publications and over 500 citings.

Office
353 East 68th Street
New York, NY 10065
Book by Phone+1(973) 718-5772

Education & Training

Memorial Sloan Kettering Cancer CenterFellowship, Urologic Surgical Oncology, 1992 - 1994
University of Oklahoma Health Sciences CenterResidency, Urology, 1989 - 1992
University of Oklahoma Health Sciences CenterResidency, Surgery, 1987 - 1989
University of Oklahoma College of MedicineClass of 1987

Certifications & Licensure

NY State Medical License 1992 - 2026
TX State Medical License 1994 - 2026
OK State Medical License 1988 - 2025
American Board of Urology Urology
Fellow of American College of SurgeonsFACS

Awards, Honors, & Recognition

Top Urologist in New York IAHCP
Greening the OR Circle of Excellence Award Practice Green Health, 2018-2020
Elite Circle Status for Greening the OR Green Practice Health, 2016-2020
Best Reviewer, Urology Journal of Urology, 2017
Teacher of the year Memorial Sloan Kettering Cancer Center, Urology Department, 2016
Fellow (FACS) American College of Surgeons
Join now to see all

Clinical Trials

A Randomized Study of the Efficacy of Low Venous Pressure General Anesthesia Versus Combined Spinal-Epidural Anesthesia in Decreasing Blood Loss During Prostate Surgery Start of enrollment: 2005 Feb 01
Completed
Phase 2
Internal Radiation Therapy in Treating Patients With Prostate Cancer Start of enrollment: 2007 Nov 01
Completed
Not Applicable
Genetic Susceptibility to Tumor Recurrence and Progression in Patients With Non-Muscle Invasive Bladder Cancer Start of enrollment: 2004 Mar 01
Completed
A Prospective Randomized Controlled Clinical Trial of Standard Versus Goal-Directed Perioperative Fluid Management (GDT) for Patients Undergoing Radical Cystectomy Start of enrollment: 2014 May 21
Completed
Phase 3
Join now to see all

Publications & Presentations

PubMed

73 citations
Preoperative serum albumin is associated with mortality and complications after radical cystectomy.
Tullika Garg, Ling Chen, Philip H. Kim, Philip T. Zhao, Harry W. Herr
BJU International. 2014-06-01
43 citations
Health-related Quality of Life for Patients Undergoing Radical Cystectomy: Results of a Large Prospective Cohort.
Matthew B. Clements, Thomas M. Atkinson, Guido Dalbagni, Yuelin Li, Andrew J. Vickers
European Urology. 2021-10-08
995 citations
Defining Early Morbidity of Radical Cystectomy for Patients with Bladder Cancer Using a Standardized Reporting Methodology
Ahmad Shabsigh, Ruslan Korets, Kinjal C. Vora, Christine M. Brooks, Angel M. Cronin
European Urology. 2009-01-01

Professional Memberships

American College of Surgeons - ACS
Member
American Society of Clinical Oncology - ASCO
Member
American Urologic Association AUA
Member
Society Female Surgeons
Member
Women in Urology
Member
Society Surgical Oncology
Member
New York Urologic Association
Member
Society of Urologic Oncology (SUO)
Member

Insurance Accepted

Aetna Choice POS II
Aetna HMO
BCBS Blue Card PPO
CIGNA HMO
CIGNA Open Access
CIGNA PPO
Empire BCBS HMO
Empire BCBS PPO
GHI PPO
Great West PPO
Humana ChoiceCare Network PPO
Multiplan PHCS PPO
Multiplan PPO
MVP Healthcare PPO
QualCare HMO
QualCare PPO
Regence Washington - Preferred Provider Network
United Healthcare - Direct Choice Plus POS
United Healthcare - Direct Options PPO
Please verify your coverage with the provider's office directly when scheduling an appointment